A detailed history of Sentry LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sentry LLC holds 8,146 shares of ABBV stock, worth $1.4 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
8,146
Previous 8,146 -0.0%
Holding current value
$1.4 Million
Previous $1.4 Billion 15.14%
% of portfolio
0.31%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$159.82 - $182.1 $479 - $546
-3 Reduced 0.04%
8,146 $1.48 Billion
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $1.12 Million - $1.26 Million
8,149 New
8,149 $1.26 Million
Q2 2023

Mar 06, 2024

BUY
$132.51 - $164.9 $66,255 - $82,450
500 Added 6.54%
8,146 $1.1 Billion
Q1 2023

Mar 06, 2024

SELL
$144.61 - $166.54 $72,738 - $83,769
-503 Reduced 6.17%
7,646 $1.22 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sentry LLC Portfolio

Follow Sentry LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry LLC with notifications on news.